Jawbone reportedly raises nearly $16M at a $3B valuation

The impending release of the Apple Watch hasn’t scared Jawbone’s investors off. Forbes is reporting that the maker of the Jawbone UP fitness bracelet is set to close a new $15.8 million round of funding that values the company at $3 billion.

[company]Jawbone[/company] is pursuing a massive $250 million funding round led by Rezvi Traverse, as was reported earlier this year. The small number of shares involved in this round indicates those plans are still on track. The $15.8 million shares are of a slightly different class than previous shares — Series 6-A preferred, which have first liquidation preference, according to a September 15 filing obtained by Forbes.

Jawbone UP, Photo by Gigaom

Jawbone UP, Photo by Gigaom

Although much of Jawbone’s promise is in its UP-branded wearable products and platform, most of its current revenue comes from its popular Jambox line of portable Bluetooth speakers. If Jawbone UP or its successors becomes a key part of either fitness tracking or the smart home, it could be a very valuable company. But investors can’t forget that it’s already selling quite a large amount of products already. TechCrunch reported last February that Jawbone has a $600 million revenue run rate projected forward to February 2015.

Jawbone’s UP fitness tracking band would appear to be one of the products currently on the market threatened by Apple’s watch, which is expected to be released early next year. But even when consumers have to choose between Apple Watch and UP, Jawbone still sees a lot of room for growth. As laid out in a post written shortly after Apple’s announcement, Jawbone said that it sees UP as a platform that the Apple Watch will be able to feed data into, and besides, the UP fitness tracker lasts for at least a week on a charge, so it can measure metrics like sleep.

What could Jawbone possibly be planning to do with $250 million in funding? You can ask founder Hosain Rahman at our Structure Connect conference taking place October 21 and 22.